Afficher la notice abrégée

dc.creatorMalliaropoulos N., Thompson D., Meke M., Pyne D., Alaseirlis D., Atkinson H., Korakakis V., Lohrer H.en
dc.date.accessioned2023-01-31T08:56:27Z
dc.date.available2023-01-31T08:56:27Z
dc.date.issued2017
dc.identifier10.1186/s12891-017-1873-x
dc.identifier.issn14712474
dc.identifier.urihttp://hdl.handle.net/11615/76219
dc.description.abstractBackground: A retrospective single centre cohort analysis was performed to evaluate an individualised radial extracorporeal shock wave therapy (rESWT) protocol for treatment of symptomatic calcific shoulder tendinopathy. Methods: 67 patients (79 Shoulders) were identified with 76 shoulders included for analysis. rESWT treatment protocol was adapted according to individual response to treatment. Variables included number of sessions, shockwave impulses, pressure and frequency. Success rate was estimated as the percentage of patients having ≥60% visual analogue score (VAS) pain decrease at follow-up. Recurrence at 1 year was recorded. Results: Using this individualised symptom guided protocol, patients underwent a mean of 7 ± 1.5 rESWT sessions, with mean pressure of 1.7 ± 0.2 bar, mean frequency of 5 ± 0.3 Hz and 2175 ± 266 impulses. The mean pre-treatment VAS score of 6.7 ± 1.1 was significantly decreased to 3.2 ± 0.8 immediately post-treatment, 2.6 ± 0.9 at 1 month, 1.7 ± 1.0 at 3 months and 0.8 ± 1.0 at 1 year follow up (α = 0.05). One-year success rate was estimated at 92% and 1-year recurrence rate was 7%. Conclusions: We conclude that in this retrospective study an individualised rESWT protocol resulted in a high success rate with low number of recurrences. Randomised controlled trials to support these findings are recommended. © 2017 The Author(s).en
dc.language.isoenen
dc.sourceBMC Musculoskeletal Disordersen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85037617611&doi=10.1186%2fs12891-017-1873-x&partnerID=40&md5=6737ce7e33f01b0fc35d28e339ea5bfd
dc.subjectadulten
dc.subjectArticleen
dc.subjectcontrolled studyen
dc.subjectdisease severityen
dc.subjectextracorporeal shock wave lithotripsyen
dc.subjectfemaleen
dc.subjectfollow upen
dc.subjecthumanen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectpopulation researchen
dc.subjectradial extracorporeal shock wave therapyen
dc.subjectrandomized controlled trialen
dc.subjectrecurrent diseaseen
dc.subjectretrospective studyen
dc.subjectshoulder diseaseen
dc.subjectsymptomatic calcific shoulder tendinopathyen
dc.subjecttendinitisen
dc.subjecttreatment responseen
dc.subjectvisual analog scaleen
dc.subjectarthropathyen
dc.subjectcalcinosisen
dc.subjectmiddle ageden
dc.subjectpathologyen
dc.subjectpersonalized medicineen
dc.subjectproceduresen
dc.subjectshock wave therapyen
dc.subjectshoulderen
dc.subjecttendinitisen
dc.subjectvascular diseaseen
dc.subjectAdulten
dc.subjectCalcinosisen
dc.subjectExtracorporeal Shockwave Therapyen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectJoint Diseasesen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPrecision Medicineen
dc.subjectRetrospective Studiesen
dc.subjectShoulder Jointen
dc.subjectTendinopathyen
dc.subjectVascular Diseasesen
dc.subjectBioMed Central Ltd.en
dc.titleIndividualised radial extracorporeal shock wave therapy (rESWT) for symptomatic calcific shoulder tendinopathy: A retrospective clinical studyen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée